Boston’s Fenway Park Gets New Cannabis Dispensary
MedMen Fenway MedMen Publicly traded cannabis company MedMen has had a turbulent year, having had to deal with management shakeups, the ousting of its co-founders and lawsuits. And, although the stock is still up about 16% year-to-date, it has fallen considerably from the $1.29 per share value it reached in February – it’s now under …
Boston’s Fenway Park Gets New Cannabis Dispensary Read More »